PIAS1 and B-cell non-Hodgkin lymphoma: In B‐cell lymphoma, PIAS1‐mediated SUMOylation of Myc leads to a longer half‐life of the protein and increased oncogenic activity, contributing to the development of B‐cell lymphoma.1023